Categories: Entertainment

Crafting Tomorrow: Thomas Abraham Headlines D-Arc Build

BENGALURU, India, July 14, 2025 /PRNewswire/ — Renowned architect and educator Thomas Abraham delivered the keynote address at D-Arc Build 2025, a national design and architecture exposition held in Bangalore during the final week of June. The three-day event brought together professionals, academics, and students for a series of exhibitions, panel discussions, and award presentations. IDeA World College, which Abraham founded, was the only academic institution invited to exhibit at the expo. The college showcased student work in interior, fashion, and graphic design, which drew steady interest from visitors and professionals alike.

- Advertisement -

In his address, Abraham spoke about the changing relationship between design education and industry practice, emphasizing the need for mentorship and applied learning as part of design training.

- Advertisement -

He also served on the jury for the Maestro Award, which recognises recent achievements in architecture and interior design across India.

- Advertisement -

The event also featured the unveiling of the Gold Collection from Abraham’s Spring 2025 line, developed in collaboration with IDeA’s fashion design students and interns. The collection was presented on the final day of the exposition.

- Advertisement -

Commenting briefly after the event, Abraham said:

- Advertisement -

IDeA World College’s ambition is simply to become the best design college in the world. I believe this exposition, which brought together some of the best designers, is another step in that direction.”

- Advertisement -

Photo: https://mma.prnewswire.com/media/2730164/D_Arc_Build_Expo.jpg

- Advertisement -

 

- Advertisement -

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/crafting-tomorrow-thomas-abraham-headlines-d-arc-build-302504176.html

- Advertisement -
PRNW Agency

Recent Posts

ITM Announces Phase 3 COMPETE Patient-Reported Quality of Life Data with n.c.a. Lu-edotreotide (ITM-11) vs. Everolimus at ASCO 2026

Exploratory analysis showed favorable patient-reported quality of life outcomes and delayed time to deterioration in…

7 hours ago

ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026

– Updated data across two dose levels of 200 mW/cm and 400 mW/cm in LA-PDAC…

7 hours ago

Fobi AI Provides Corporate Update Regarding FFCTO Revocation Process and Q3 Interim Filings

May 29, 2026 21:18 ET  | Source: Fobi AI Inc. VANCOUVER, BC, May 29, 2026…

14 hours ago

Crypto News Today: AlphaPepe Presale Stage 17 Nears Sell Out While XRP Price Prediction Eyes $7.00

MONACO, May 29, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe as…

14 hours ago